EXCLUSIVE: Disney Entertainment Television has chosen its participants for the 2025-26 Directing and Writing Programs, talent development initiatives which connect emerging writers and directors with ...

Even as some instructors remain fervently opposed to chatbots, other writing and English professors are trying to improve them. Attitudes toward artificial intelligence are evolving, with some ...

Courtney Peña-Lima is an associate director at the Biosciences Grant Writing Academy at Stanford University in California and a writing instructor at the Stanford University School of Medicine. Troy ...

What if you could combine the simplicity of Arduino with the power of a Linux-based processor, all in one compact device? Enter the Arduino Uno Q, a new development board designed to handle everything ...

Is the Arduino Uno Q the missing piece in your next project? With its hybrid design that fuses the precision of a microcontroller with the flexibility of a Linux-based single-board computer, this ...

The state of Utah is allowing artificial intelligence to prescribe medication refills to patients without direct human oversight in a pilot program public advocates call “dangerous.” The program is ...

FIRST ON FOX: Stanford University is promoting required reading courses that incorporate anti-ICE sentiments, racial identity politics and all-male drag shows, resulting in criticism from a leading ...

Can Liverpool do the double over runaway Premier League leaders Arsenal? Trump pulls US out of more than 30 UN bodies Fresno County farmer buys land, not for what's planted, but for what's underneath ...

The Maslow Family Graduate Program in Creative Writing at Wilkes University is hosting evening readings in a variety of genres, featuring alumni, faculty, and guest artists. These readings are free ...

Famed author and University of Chicago alumna Susan Sontag, AB’51, once wrote: “I write—and talk—in order to find out what I think.” A new course in the College is allowing first-years to put that ...

Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene-writing program, inking a deal that lets it in on a prospect for alpha-1 antitrypsin deficiency (AATD) through a $150 million ...